In vivo: nanocarriers to deliver precision chemotherapy

[Maxone73]

A bit premature, but...

Tests verified the ATP-modified PLGA nanoparticles were well tolerated in mice upon multiple systemic injections. They were able to recruit dendritic cells, the immune cells that recognize tumor antigens and bring specialized immune cells to fight off tumors.

"Moreover, the nanoparticles were shown to control the release of paclitaxel to minimize its systemic toxicity," Yeo said.

miragenews.com/scientists-d...

[j-o-h-n]

Mice have all the fun....

Good Luck, Good Health and Good Humor.

j-o-h-n